ROLE SUMMARY:
As part of Information Managements Clinical Trial Solutions team, the Senior Information Manager (IM) serves as the Product Owner for one or more solutions that support clinical trial data processing. The IM forms a critical partnership with Digital and Business Process Owners and plays a key role in the lifecycle of an application, while providing governance, leadership, and ensuring data quality and compliance are maintained. The initial primary application focus will be the support of Oracle Data Management Workbench (DMW).
ROLE RESPONSIBILITIES:
* Planning and implementing business solutions that enable business process
* Providing strategic direction and operational oversight of applications to meet business needs
* Driving standard processes and technical controls to ensure the integrity, authenticity, and reliability of applications
* Representing IM in cross functional work groups to support portfolio and business needs
* Communication of plans and decisions to ensure alignment of expectations across business lines
* Overseeing the ongoing maintenance and operations of applications
* Support application SDLC including defining requirements, user acceptance testing, training and rollout
* Driving application best practices
BASIC QUALIFICATIONS:
* Bachelor's degree in a Life Science, Computer Science or equivalent
* Minimum of 10 years of relevant experience in a pharmaceutical, biotech or CRO
* Strong communication (written and oral), decision-making, influencing, negotiation, and project management skills
* Technical skills and experience using relational databases (Oracle, etc.)
* Proficiency in the use of Microsoft Office Suite of tools (Outlook, Word, Excel, etc.)
* Understanding of drug development process and related data flow
PREFERRED QUALIFICATIONS
* Oracle Life Science Hub (LSH) and Data Management Workbench (DMW)
* Oracle InForm and Central Designer
Other Job Details
Eligible for Employee Referral Bonus
Last Day to Apply: April 20th 2021
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Information & Business Tech
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.